DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management. The company provides Guided Forms, which enable complex forms to be filled via an interactive and step-by-step process; Click that supports no-signature-required agreements for standard terms and consents; Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Payments that enables customers to collect signatures and payment; Remote Online Notary is a solution using audio-visual and identify verification technologies to enable notarization; and Monitor using advanced analytics to track DocuSign eSignature web, mobile, and API account. It offers industry-specific cloud offerings, including Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; Rooms for Mortgage, which offers digital workspace to create and close mortgages; FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise, commercial, and small businesses. The company was incorporated in 2003 and is headquartered in San Francisco, California.
DocuSign Price Performance
Shares of DOCU traded up $2.00 during trading hours on Friday, reaching $74.34. 3,355,320 shares of the company traded hands, compared to its average volume of 3,010,007. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.06. The stock has a market capitalization of $14.86 billion, a PE ratio of -165.20 and a beta of 1.21. DocuSign has a fifty-two week low of $55.86 and a fifty-two week high of $314.70. The stock has a fifty day simple moving average of $66.69 and a 200 day simple moving average of $87.05.
DocuSign (NASDAQ:DOCU - Get Rating) last posted its quarterly earnings data on Thursday, June 9th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.04). The business had revenue of $588.69 million for the quarter, compared to analysts' expectations of $581.85 million. DocuSign had a negative return on equity of 17.17% and a negative net margin of 4.00%. DocuSign's revenue for the quarter was up 25.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.03) earnings per share. As a group, research analysts predict that DocuSign will post -0.48 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on DOCU shares. Citigroup cut their price target on shares of DocuSign from $114.00 to $90.00 and set a "buy" rating on the stock in a report on Friday, June 10th. Piper Sandler lowered shares of DocuSign from a "neutral" rating to an "underweight" rating and cut their target price for the company from $65.00 to $54.00 in a research note on Wednesday, July 20th. Bank of America lowered shares of DocuSign from a "buy" rating to a "neutral" rating and cut their target price for the company from $120.00 to $72.00 in a research note on Friday, June 10th. William Blair lowered shares of DocuSign from an "outperform" rating to a "market perform" rating in a research note on Friday, June 10th. Finally, Wolfe Research cut shares of DocuSign from a "market perform" rating to an "underperform" rating and set a $50.00 target price for the company. in a report on Monday, June 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $131.20.